series

Pushing the boundaries of science

Patients Science Innovation Research and development Antibiotics Infectious diseases

Published

Scientists in Roche Pharma Research and Early Development are pushing boundaries to make medical breakthroughs for people and society. Here you can discover some of the areas where they are leading the field.

Controlling the immune system: from autoimmunity to chronic inflammation
Roche is exploring the expanding scope of immunology therapy
July 22, 2026
Transforming autoimmune treatment: How data-driven therapies are changing patient outcomes
Three diseases. One mission. Roche combines breakthrough technologies with deep immunology expertise and real-world data to transform treatment for lupus, IBD, and COPD
July 06, 2026
Our holistic ophthalmology vision: From prevention to vision restoration
How AI and Real-World Data are unlocking innovation to address high-burden eye diseases at scale
May 20, 2026
Roche’s Institute of Human Biology: The scientists transforming the future of drug discovery with human model systems
With a new research building in Basel, Roche’s IHB gains a new home, advancing drug discovery with experimental systems mimicking human biology.
March 30, 2026
Series
Accelerating drug discovery with organoids
Scientists review progress in the field of organoid technology and exciting future opportunities to apply these human model systems in industry settings.
November 27, 2025
Series
Modelling myelination
Roche scientists develop a new neural organoid system that provides a tool to test for safety and efficacy of medicines that impact the insulating layer surrounding neurons.
October 28, 2025
Advancing novel classes of antibiotics
Roche’s commitment to creating and developing researching and developing new medicines to tackle drug resistance
February 03, 2025
Roche’s lifesaving legacy in antibiotic innovation
Finding new ways to kill bacteria is crucial against antimicrobial resistance. For Roche, it's been a 45-year legacy of innovative antibiotics and saving lives.
February 03, 2025
An immune upgrade for organoids
Engineering breakthrough for intestinal epithelial organoids with tissue-resident immune cells recapitulate drug-induced, immune-mediated toxicities.
August 21, 2024
Charting a new course in Alzheimer’s disease
Roche pioneering a new patient journey
July 24, 2025
Engineering models of the human gut
New “organoid-on-a-chip” system merges stem cell biology and innovation in engineering to better represent organs for research and development.
June 14, 2024
Doubling our vision
By combining a unique medical device with new medicines, Roche is turning breakthrough discoveries into groundbreaking inventions for patients with retinal disease
May 27, 2024
Redefining Parkinson’s disease
Redefining Parkinson's Disease: Science, technology, and passion converge to revolutionise the understanding and treatment of neurodegenerative diseases, offering new hope for patients and families.
April 15, 2024
Defining hallmarks of stem cells
A new review from Roche scientists describe stem cells’ unique and shared features, laying the foundation of what is known about them and mapping new approaches in drug discovery
February 02, 2024
New era of antibiotics potentially in sight after more than 50 years
By finding a new class of antibiotics, Roche’s scientists could contribute to reducing the globally growing number of deaths related to hospital-acquired bacterial infections
January 03, 2024
Series
The RNA Hub - An integrated multidisciplinary research community
Roche is shaking up the drug development process for new RNA-based medicines
October 16, 2023
Fighting inflammation in the eye
How a potential new molecule for retinal diseases could help close a gap of unmet medical need
September 15, 2023
An innovative hub for innovative medicines
Roche is shaking up the drug development process for new RNA-based medicines
June 07, 2023
From idea, to molecule, to medicine
The step-by-step evolution of a potential new approach to treating cancer.
May 23, 2023
Modeling the future
Roche launches the Institute of Human Biology to pioneer new approaches for drug discovery and development, leveraging human model systems such as organoids
May 04, 2023
Meet the antibody engineers
How teams across Roche are tweaking versatile immune tools to develop new treatments
April 11, 2023
Harnessing immune power against tumours
How Roche follows the science to continue improving on bold new therapeutic strategies.
December 14, 2022
Pushing the boundaries of science: Following the fibroblasts
How describing the structural cells of tissues sheds new light on autoimmune disease
September 16, 2022
Reaching new antibody heights
Hear reflections from Roche pRED scientists on the science and innovation behind the pioneering advances in antibody technology for novel antibody therapeutics.
January 28, 2022

Discover more

Roche Careers
Find jobs and learn more about exciting career opportunities at Roche, one of the world's leading research-based healthcare companies.
Roche Pharma R&D (pRED)
Innovation
From Alzheimer’s disease to antimicrobial resistance, our Research and Development (R&D) focuses on high-burden diseases to address unmet needs and improve patient outcomes.
Partnering
Innovation
At Roche Partnering, we are passionate about science: yours and ours. Through partnerships, we hope that together we can build a better future with medicines that make a real difference to patients.
Innovation
Innovation
In everything we do, we are guided by the needs of patients and their loved ones, acting with integrity, courage and passion.

More stories

See all stories

The power of foresight: How AI-enabled prediction can reduce the risk of nighttime lows
AI-enabled algorithms are transforming diabetes care by predicting nighttime lows up to 7 hours in advance. Real-world data shows a 31% drop in severe hypoglycemia, offering proactive safety and peace of mind.
August 05, 2026
Controlling the immune system: from autoimmunity to chronic inflammation
Roche is exploring the expanding scope of immunology therapy
July 22, 2026
Haemophilia A in infants
Learn about haemophilia A in infants, its impact on families, key symptoms to watch for, and why early diagnosis and prophylactic treatment are crucial for better outcomes.
July 09, 2026